United Health Products, Inc.

United Health Products, Inc.

OOTC:UEEC
0.04
USD
-0.01
(-11.60%)
-0.01EPS
14.83MMarket Cap

Total Valuation

USD

As of June 30, 2026, United Health Products, Inc. carries a market capitalization of 14.83M, placing it among publicly traded companies globally. Its enterprise value stands at 17.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap14.83M
Enterprise Value17.14M

Share Statistics

As of June 30, 2026, United Health Products, Inc. has 261.59M shares outstanding.

Shares Outstanding261.59M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio-3.34
P/TBV Ratio-3.32
P/FCF Ratio-15.44
P/OCF Ratio-15.44

Financial Position

As of June 30, 2026, United Health Products, Inc. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -52.47, indicating conservative leverage, while an interest coverage ratio of -3.47 demonstrates limited ability to service its debt obligations.

Current Ratio0.02
Quick Ratio0.01
Debt / Equity-52.47
Debt / EBITDA-2.51
Interest Coverage-3.47

Financial Efficiency

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -863.36, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 10.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-863.36
Employee Count10.00

Stock Price Statistics

USD

As of the close on November 16, 2026, United Health Products, Inc.'s stock has declined approximately 29.84% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.05.

52-Week Price Change-29.84%
50-Day Moving Average0.04
200-Day Moving Average0.05

Income Statement

USD

Over the twelve months ended June 30, 2026, United Health Products, Inc. generated - - in revenue and converted that into -1.42M in net income, yielding earnings per share of -0.01. EBITDA reached -927,566.00, while operating income came in at -930,333.00.

Operating Income-930,333.00
Pretax Income-1.42M
Net Income-1.42M
EBITDA-927,566.00
EBIT-930,333.00
Earnings Per Share (EPS)-0.01

Balance Sheet

USD

As of June 30, 2026, United Health Products, Inc. holds 24,495.00 in cash and equivalents against 2.33M in total debt, resulting in a net debt position of 2.31M. Total book value stands at -4.44M, with working capital of -4.12M providing operational flexibility.

Cash & Cash Equivalents24,495.00
Total Debt2.33M
Net Debt2.31M
Equity (Book Value)-4.44M
Book Value Per Share-0.02
Working Capital-4.12M

Cash Flow

USD

United Health Products, Inc. produced -950,636.00 in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-950,636.00
Free Cash Flow-950,636.00

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -6.48: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -6.57, meaning United Health Products, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-6.57
FCF Yield-6.48

Scores

As of June 30, 2026, United Health Products, Inc. has an Altman Z-Score of -542.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-542.73